Injury markers in two models of cerebral ischemia;Análisis comparativo de marcadores de lesión en modelos de isquemia cerebral focal y global en ratas

Biomedica

Volumn 33, Issue 2, 2013, Pages 292-305

  Céspedes, Ángel Enrique ^a,b   Arango, César Augusto ^c,d   Cardona, Gloria Patricia ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSIDAD DEL TOLIMA   (Colombia)

^c FUNDACIÓN VALLE DEL LILI   (Colombia)

^d UNIVERSIDAD ICESI   (Colombia)

Author keywords

Ischemia; Nerve degeneration; Rats; Stroke; Tau proteins; Wistar

Indexed keywords

BIOLOGICAL MARKER; FLUORESCEIN DERIVATIVE; FLUORO JADE; GLIAL FIBRILLARY ACIDIC PROTEIN; TAU PROTEIN;

ANIMAL; BRAIN ISCHEMIA; COMPARATIVE STUDY; DIAGNOSTIC USE; DISEASE COURSE; DISEASE MODEL; FEMALE; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; RAT; TIME; WISTAR RAT;

ANIMALS; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; FLUORESCEINS; GLIAL FIBRILLARY ACIDIC PROTEIN; PHOSPHORYLATION; RATS; RATS, WISTAR; TAU PROTEINS; TIME FACTORS;

EID: 84886782057     PISSN: 01204157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Dearborn JL, McCullough LD. Perception of risk and knowledge of risk factors in women at high risk for stroke. Stroke. 2009;40:1181-6. http://dx.doi.org/10.1161/ STROKEAHA.108.543272
2. Arango CA, Escobar M, Cardona GP, Pimienta H. Fisiopatología de la isquemia cerebral focal: aspectos básicos y proyección a la clínica. Rev Neurol. 2004;39:156-65.
3. Myers GL, Christenson RH, Cushman M, Ballantyne CM, Cooper GR, Pfeiffer CM, et al. Biomarcadores emergentes para la prevención primaria de la enfermedad cardiovascular y del accidente cerebrovascular. Acta Bioquím Clín Latinoam. 2010;44:75-100.
4. Rodrigo J, Fernández AP, Serrano J, Peinado MA, Martínez A. The role of free radicals in cerebral hypoxia and ischemia. Free Radical Biol Med. 2005;39:26-50. http:// dx.doi.org/10.1016/j.freeradbiomed.2005.02.010
5. Wu D. Neuroprotection in experimental stroke with targeted neurotrophins. NeuroRX. 2005;2:120-8.
6. Carmichael ST. Rodent models of focal stroke: Size, mechanism, and purpose. NeuroRX. 2005;2:396-409.
7. Durukan A, Tatlisumak T. Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav.2007;87:179-97.http://dx.doi.org/10.1016/j.pbb. 2007.04.015
8. Graham SM, McCullough LD, Murphy SJ. Animal models of ischemic stroke: Balancing experimental aims and animal care. Comp Med. 2004;54:486-96.
9. Sicard KM, Fisher M. Animal models of focal brain ischemia. Exp Transl Stroke Med. 2009;1:7. http://dx.doi. org/10.1186/2040-7378-1-7
10. Gerriets T, Stolz E, Walberer M, Müller C, Rottger C, Kluge A, et al. Complications and pitfalls in rat stroke models for middle cerebral artery occlusion: A comparison between the suture and the macrosphere model using magnetic resonance angiography. Stroke. 2004;35:2372-7.
11. Hossmann KA. Pathophysiology and therapy of experimental stroke. Cell Mol Neurobiol. 2006;26:1055-81. http://dx.doi.org/10.1007/s10571-006-9008-1
12. Pulsinelli WA, Brierley JB. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke. 1979;10:267-72. http://dx.doi.org/10.1161/01.STR.10.3.267
13. Longa ZE, Weinstein PR, Carlson S, Cummins R. reversible middle cerebral artery occlusion without craniectomy in rats. Stroke.1989;20:84-91. http://dx.doi. org/10.1161/01.STR.20.1.84
14. Traystman RJ. Animal models of focal and global cerebral ischemia. ILAR J. 2003;44:85-95.
15. Pulsinelli WA, Buchan AM. The four-vessel occlusion rat model: Method for complete occlusion of vertebral arteries and control of collateral circulation. Stroke.1988;19:913-4. http://dx.doi.org/10.1161/01.STR.19.7.913
16. Ginsberg MD, Busto R. Rodent models of cerebral ischemia. Stroke. 1989;20:1627-42. http://dx.doi.org/10.1161/01.STR.20. 12.1627
17. Belayev L, Busto R, Zhao W, Fernández G, Ginsberg MD. Middle cerebral artery occlusion in the mouse by intraluminal suture coated with poly-L-lysine: Neurological and histological validation. Brain Res. 1999;833:181-90. http://dx.doi.org/10.1016/S0006-8993(99)01528-0
18. Wang J, Shen J, Gao Q, Ye Z, Shang S, Liang H, et al. Ischemic postconditioning protects against global cerebral ischemia/reperfusion-induced injury in rats. Stroke.2008;39:983-90.http:/ /dx.doi.org/10.1161/ STROKEAHA.107.499079
19. Wen Y, Yang S, Liu R, Simpkins JW. Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. Brain Res. 2004;1022:30-8. http://dx.doi. org/10.1016/j.brainres.2004.05.106
20. Popa-Wagner A, Schřder E, Walker LC, Kessler C. B-amyloid precursor protein and b-amyloid peptide immunoreactivity in the rat brain after middle cerebral artery occlusion. Stroke. 1998;29:2196-202. http://dx.doi. org/10.1161/01.STR.29.10.2196
21. Buée L, Bussiére T, Buée-Scherrer V, Delacourte A, Hof PR. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev. 2000;33:95-130.http://dx.doi.org/10.1016/S0165-0173 (00)00019-9
22. Briones TL, Woods J, Wadowska M, Rogozinska M, Nguyen M. Astrocytic changes in the hippocampus and functional recovery after cerebral ischemia are facilitated by rehabilitation training. Behav Brain Res. 2006;171:17-25. http://dx.doi.org/10.1016/j.bbr.2006.03.011
23. Li Y, Chopp M, Zhang ZG, Zhang RL. Expression of glial fibrillary acidic protein in areas of focal cerebral ischemia accompanies neuronal expression of 72-kDa heat shock protein. J Neurol Sci. 1995;128:134-42. http://dx.doi. org/10.1016/0022-510X(94)00228-G
24. Yrjänheikki J, Koistinaho J, Kettunen M, Kauppinen RA, Appel K, Hull M, et al. Long-term protective effect of atorvastatin in permanent focal cerebral ischemia. Brain Res. 2005;1052:174-9. http://dx.doi.org/10.1016/j. brainres.2005.06.004
25. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke. 1986;17:472-6. http://dx.doi.org/10. 1161/01.STR.17.3.472
26. Yang Y, Shuaib A, Li O, Siddiqui MM. Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization. Brain Res. 1998;804:169-76. http://dx.doi.org/10.1016/S0006-8993(98)00410-7
27. Joshi CN, Jain SK, Murthy PSR. An optimized triphenyltetrazolium chloride method for identification of cerebral infarcts. Brain Res Brain Res Protoc. 2004;13:11-7. http://dx.doi.org/10.1016/j.brainresprot.2003. 12.001
28. Céspedes-Rubio A, Wandosell F, Cardona-Gómez GP. p120 catenin/an-catenin are molecular targets in the neuroprotection and neuronal plasticity mediated by atorvastatin after focal cerebral ischemia. J Neurosci Res. 2010;88:3621-34. http://dx.doi.org/10.1002/jnr.22511
29. Roulston CL, Callaway JK, Jarrott B, Woodman OL, Dusting GJ. Using behaviour to predict stroke severity in conscious rats: Post-stroke treatment with 3',4'-dihydroxyflavonol improves recovery. Eur J Pharmacol. 2008;584:100-10. http://dx.doi.org/10.1016/j.ejphar.2008.01.046
30. Gulinello M, Lebesgue D, Jover-Mengual T, Zukin RS, Etgen AM. Acute and chronic estradiol treatments reduce memory deficits induced by transient global ischemia in female rats. Horm Behav. 2006;49:246-60. http://dx.doi. org/10.1016/j.yhbeh.2005.07.010
31. Kuge Y, Minematsu K, Yamaguchi T, Miyake Y. Nylon monofilament for intraluminal middle cerebral artery occlusion in rats. Stroke. 1995;26:1655-8. http://dx.doi. org/10.1161/01.STR.26.9.1655
32. Schmid-Elsaesser R, Zausinger S, Hungerhuber E, Baethmann A, Reulen HJ, García JH. A critical reevaluation of the intraluminal thread model of focal cerebra ischemia: Evidence of inadvertent premature reperfusion and subarachnoid hemorrhage in rats by laser-Doppler flowmetry. Stroke. 1998;29:2162-70. http://dx.doi. org/10.1161/01.STR.29.10.2162
33. Braeuninger S, Kleinschnitz C. Rodent models of focal cerebral ischemia: Procedural pitfalls and translational problems. Exp Transl Stroke Med. 2009;1:8. http://dx.doi. org/10.1186/2040-7378-1-8
34. Duckworth EA, Butler TL, De Mesquita D, Collier SN, Collier L, Pennypacker KR. Temporary focal ischemia in the mouse: Technical aspects and patterns of Fluoro-Jade evident neurodegeneration. Brain Res. 2005;1042:29-36. http://dx.doi.org/10.1016/j.brainres.2005.02.021
35. Gupta YK, Briyal S. Animal models of cerebral ischemia for evaluation of drugs. Indian J Physiol Pharmacol. 2004;48:379-94.
36. Herz RCG, Kasbergen CM, Hillen B, Versteeg DHG, Wildt DJ. Rat middle cerebral artery occlusion by an intraluminal thread compromises collateral blood flow. Brain Res. 1998;791:223-8.http://dx.doi.org/10.1016/S0006-8993 (98)00106-1
37. Hossmann KA. Cerebral ischemia: Models, methods and outcomes. Neuropharmacology. 2008;55:257-70. http:// dx.doi.org/10.1016/j.neuropharm.2007.12.004
38. Peña-Tapia PG, Díaz AH, Torres JL. Oclusión endovascular permanente de la arteria cerebral media en ratas Wistar: descripción del abordaje a través de la arteria carótida interna. Rev Neurol. 2004;39:1011-6.
39. Smrcka M, Otevrel F, Kuchtícková Š, Horký M, Jurán V, Duba M, et al. Experimental model of reversible focal ischaemia in the rat. Scripta Medica. 2001;74:391-8.
40. Woitzik J, Schneider UC, Thome C, Schroeck H, Schilling L. Comparison of different intravascular thread occlusion models for experimental stroke in rats. J Neurosci Methods.2006;151:224-31.http://dx.doi.org/10.1016/j. jneumeth.2005.07.007
41. Zhao H, Shimohata T, Wang JQ, Sun G, Schaal DW, Sapolsky RM, et al. AKT contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci.2005;25:9794-806.http://dx.doi.org/10.1523/ JNEUROSCI.3163-05.2005
42. Sicard KM, Fisher M. Emerging drugs for acute ischemic stroke. Expert Opin Emerg Drugs. 2009;14:33-42. http://dx.doi.org/10.1517/14728210902748365
43. Woodruff TM, Thundyil J, Tang SC, Sobey CG, Taylor SM, Arumugam TV. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener. 2011;6:11. http://dx.doi.org/10.1186/1750-1326-6-11
44. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci. 1999;22:391-7. http://dx.doi.org/10.1016/S0166-2236 (99) 01401-0
45. Culmsee C, Krieglstein J. Mechanisms of neuronal degeneration after ischemic stroke-Emerging targets for novel therapeutic strategies. Drug Discov Today. 2005;2:463-70. http://dx.doi.org/10.1016/j.ddmec.2005.11.006
46. Wieloch T, Nikolich K. Mechanisms of neural plasticity following brain injury. Curr Opin Neurobiol. 2006;16:258-64. http://dx.doi.org/10.1016/j.conb.2006.05.011
47. Gutiérrez-Vargas J, Castro-Álvarez JF, Velásquez-Carvajal D, Montañez-Velásquez MN, Céspedes-Rubio A, Cardona-Gómez GP. Rac1 activity changes are associated with neuronal pathology and spatial memory long-term recovery after global cerebral ischemia. Neurochem Int. 2010;57:762-73. http://dx.doi.org/10.1016/j. neuint.2010.08.014
48. Castro-Álvarez JF, Gutiérrez-Vargas J, Darnaudery M, Cardona-Gómez GP. ROCK inhibition prevents tau hyperphosphorylation and p25/CDK5 increase after global cerebral ischemia. Behav Neurosci. 2011;125:465-72. http://dx.doi.org/10.1037/a0023167
49. Wen Y, Yang SH, Liu R, Pérez EJ, Brun-Zinkernagel AM, Koulen P, et al. Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats Biochim Biophys Acta. 2007;1772:473-83. http://dx.doi. org/10.1016/j.bbadis.2006.10.011
50. Piedrahita D, Hernández I, López-Tobón A, Fedorov D, Obara B, Manjunath BS, et al. Silencing of CDK5 reduces neurofibrillary tangles in transgenic Alzheimer's mice. J Neurosci. 2010;30:13966-76. http://dx.doi.org/10.1523/ JNEUROSCI.3637-10.2010